Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly
出版年份 2016 全文链接
标题
Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 13, Issue 3, Pages 574-578
出版商
Informa UK Limited
发表日期
2016-12-19
DOI
10.1080/21645515.2016.1232787
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial
- (2015) Javier Diez-Domingo et al. VACCINE
- Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
- (2014) Roman Chlibek et al. VACCINE
- Similar herpes zoster incidence across Europe: results from a systematic literature review
- (2013) Sybil Pinchinat et al. BMC INFECTIOUS DISEASES
- Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
- (2013) R. Chlibek et al. JOURNAL OF INFECTIOUS DISEASES
- The global epidemiology of herpes zoster
- (2013) B. P. Yawn et al. NEUROLOGY
- Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su)
- (2013) Himal Lal et al. Human Vaccines & Immunotherapeutics
- A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
- (2012) Isabel Leroux-Roels et al. JOURNAL OF INFECTIOUS DISEASES
- Current issues with the immunization program in Japan: Can we fill the “vaccine gap”?
- (2012) Akihiko Saitoh et al. VACCINE
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Varicella zoster virus latency
- (2011) Emily Eshleman et al. Future Virology
- Advances in the understanding of the pathogenesis and epidemiology of herpes zoster
- (2010) Anne A. Gershon et al. JOURNAL OF CLINICAL VIROLOGY
- Herpes zoster: Burden of disease in France
- (2010) S. Gonzalez Chiappe et al. VACCINE
- Herpes Zoster Pain, Postherpetic Neuralgia, and Quality of Life in the Elderly
- (2010) Gisèle Pickering et al. Pain Practice
- Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response
- (2009) Janet E McElhaney Expert Review of Vaccines
- Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture
- (2009) Nozomu Toyama et al. JOURNAL OF MEDICAL VIROLOGY
- Herpes Zoster (Shingles) and Postherpetic Neuralgia
- (2009) Priya Sampathkumar et al. MAYO CLINIC PROCEEDINGS
- Existe-t-il des différences d’immunogénicité et de tolérance des vaccins en fonction du mode d’injection ?
- (2008) F. Ajana et al. MEDECINE ET MALADIES INFECTIEUSES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now